Recent News
Dec 29, 2025 — Mesoblast drew $75 million from a new five-year credit facility provided by a major shareholder, repaid an existing senior secured loan, and retains the option to draw a further $50 million through June 30, 2026; the facility carries an 8.00% fixed interest rate and includes five‑year warrants exercisable at a premium to recent VWAP.
Dec 21, 2025 — Analyst one‑year price targets were revised higher, lifting the average one‑year target to $20.25 per share from earlier estimates and showing a narrower range of analyst expectations.
Feb 20, 2026 — Company announced a webcast to present operational highlights and financial results for the half year ended Dec. 31, 2025, scheduled for Feb. 26, 2026 (with archive availability on the investor page).
Technical Analysis
ADX registers 9.51, indicating no prevailing trend; directional movement shows DI+ at 30.47 with a peak-and-reversal pattern (bearish) while DI‑ sits at 33.59 with a peak-and-reversal pattern (bullish), implying a tug-of-war between buyers and sellers and a likely rangebound near-term price bias relative to WMDST’s over‑valued assessment.
MACD equals -0.30 with the signal at -0.28 and a peak-and-reversal MACD_trend; negative and declining MACD denotes bearish momentum and no bullish MACD/signal crossover to offset that downside pressure.
MRO stands at -1.96 (negative), which indicates price sits below the calculated target and suggests upward pressure toward the target; given the small magnitude, expect only modest mean-reversion potential against the broader valuation headwind.
RSI of 49.02 with a decreasing trajectory signals neutral-to-weak momentum, consistent with sideways consolidation rather than a decisive directional move.
Price relationships: last close $16.91 sits marginally above the 20‑day average ($16.89) and 12‑day EMA ($16.95, decreasing), below the 50‑day average ($17.99), and above the 200‑day average ($15.44). Bollinger band midrange places the stock near the band center between $16.19 (lower 1x) and $17.58 (upper 1x), supporting a limited‑range outlook with defined intraday support near $16.35 (super trend lower).
Ichimoku components place price beneath Senkou A ($19.29) and Senkou B ($17.80) while below the Kijun‑sen ($17.45) and marginally below the Tenkan‑sen ($16.96), reinforcing the neutral-to-bearish technical posture until price clears the cloud boundary.
Volatility and volume: 42‑day volatility of 4% and a 10‑day average volume of 171,371 versus a 200‑day average of 228,025 suggest current trading interest slightly below longer-term norms; 42‑day beta 2.18 and 52‑week beta 1.60 indicate elevated sensitivity to market moves, amplifying swing potential despite the currently weak trend strength.
Fundamental Analysis
Revenue growth registers 20.50% (revenue growth = 0.20504), while reported quarter‑over‑quarter and year‑over‑year revenue growth figures read 0.0% (each), requiring attention to reporting definitions; WMDST uses the 20.50% figure when aligning growth to valuation implications. QoQ revenue change shows 0.0% and YoY revenue change shows 0.0% as reported.
Cash flow dynamics: beginning period cash stood at $144,719,000 and ending cash at $129,975,000, a cash flow delta of $-14,744,000; capital expenditures $-133,000 and operating cash flow reported at $0. Free cash flow equals $-15,691,000 with reported free cash growth of 2.86% (freeCashGrowth = 0.02858), a positive reading that sits above the industry peer mean free cash growth of -54.89% and above the industry peer median and range, indicating comparatively stronger free cash growth versus peers on the provided basis.
Free cash growth quarter‑over‑quarter reads -126.30% (freeCashGrowthQoQ = -1.26297) and year‑over‑year -181.40% (freeCashGrowthYoY = -1.81401) as reported; those large negative percentages reflect short-term volatility in cash generation and warrant monitoring of upcoming reported cash flow items during the next report date (Apr. 28, 2026).
Valuation metrics: forward EPS $0.0425 produces a forward P/E of 403.51, markedly higher than the industry peer mean forward P/E of 56.00 and the industry peer median near -0.84; that divergence places valuation well above peers on a forward earnings basis and aligns with WMDST’s determination that the current valuation is over‑valued. WMDST values the stock as over‑valued given the extreme forward P/E relative to peer central tendency and the negative free cash flow in absolute terms.
Targets and range: analyst price target mean sits at $19.22 with a high of $33.74 and a low of $9.13; the current last close of $16.91 lies below the mean target but well below the upper tail, reinforcing WMDST’s caution on valuation and the necessity for fundamental inflection to support material upside.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-01-27 |
| NEXT REPORT DATE: | 2026-04-28 |
| CASH FLOW | Begin Period Cash Flow | $ 144.7 M |
| Operating Cash Flow | $ 0.00 | |
| Capital Expenditures | $ -133.00 K | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | $ -14.74 M | |
| End Period Cash Flow | $ 130.0 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | — | |
| EPS Actual | — | |
| EPS Difference | — | |
| EPS Surprise | — | |
| Forward EPS | $ 0.04 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | — | |
| Price To Earnings QoQ | — | |
| Price To Earnings YoY | — | |
| Price To Earnings IPRWA | — | |
| PE/G Ratio | — | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 403.507 | |
| Forward PE/G | — | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | — | |
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ -33.00 M | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 0.0 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 20.504 % | |
| Revenue Growth QoQ | 0.0 % | |
| Revenue Growth YoY | 0.0 % | |
| Revenue Growth IPRWA | high: 71.991 % MESO: 20.504 % median: 3.233 % mean: 2.756 % low: -83.784 % |
|
| Earnings Growth | — | |
| Earnings Growth QoQ | — | |
| Earnings Growth YoY | — | |
| Earnings Growth IPRWA | — | |
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ -15.69 M | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | 2.858 % | |
| Free Cash Growth QoQ | -126.297 % | |
| Free Cash Growth YoY | -181.401 % | |
| Free Cash Growth IPRWA | high: 124.18 % MESO: 2.858 % mean: -54.893 % median: -69.41 % low: -77.378 % |
|
| Free Cash To Net Income | — | |
| Cash Flow Margin | — | |
| Cash Flow To Earnings | — | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |